Vraylar and Appetite - increased - a phase IV clinical study of FDA data

Summary:

Appetite - increased is reported as a side effect among people who take Vraylar (cariprazine hydrochloride), especially for people who are female, 30-39 old, have been taking the drug for < 1 month also take Lamictal, and have Bipolar disorder.

The phase IV clinical study analyzes which people have Appetite - increased when taking Vraylar. It is created by eHealthMe based on reports of 5,938 people who have side effects when taking Vraylar from the FDA, and is updated regularly.

What is Vraylar?

Vraylar has active ingredients of cariprazine hydrochloride. eHealthMe is studying from 6,136 Vraylar users. Check the latest studies of Vraylar.

What is Appetite - increased?

Appetite - increased (increased appetite is when you want to eat much more often or in larger quantities than your body requires) is found to be associated with 1,600 drugs and 2,026 conditions by eHealthMe. Check the latest studies of Appetite - increased.

On Jul, 15, 2026

5,938 people reported to have side effects when taking Vraylar.
Among them, 53 people (0.89%) have Appetite - increased.

Could Vraylar cause Appetite - increased?

Among these 53 people:

How long have people been on Vraylar when they have Appetite - increased? *

What is the gender of people who have Appetite - increased when taking Vraylar? *

female: 63.04 %
male: 36.96 %

What is the age of people who have Appetite - increased when taking Vraylar? *

What are other drugs people take besides Vraylar? *

What are other side effects people have besides Appetite - increased? *

Weight Increased: 24 people, 45.28%
Drowsiness: 14 people, 26.42%
Fatigue (feeling of tiredness): 11 people, 20.75%
Feeling Abnormal: 9 people, 16.98%
Stress And Anxiety: 8 people, 15.09%
Weakness: 7 people, 13.21%
Depression: 6 people, 11.32%
Dyspnea (difficult or laboured breathing): 6 people, 11.32%
Nausea (feeling of having an urge to vomit): 5 people, 9.43%
Bipolar Disorder (mood disorder): 5 people, 9.43%

What are the existing conditions these people have? *

Bipolar Disorder (mood disorder): 17 people, 32.08%
Depression: 8 people, 15.09%
Stress And Anxiety: 6 people, 11.32%
Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract): 5 people, 9.43%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 9.43%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 9.43%
Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 4 people, 7.55%
Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 4 people, 7.55%
Post-Traumatic Stress Disorder: 3 people, 5.66%
Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 3 people, 5.66%

* Approximation only. Some reports may have incomplete information.

Do you take Vraylar and have Appetite - increased?

- Check whether Appetite - increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vraylar:

Vraylar (6,136 reports)

Browse all side effects of Vraylar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Appetite - increased:

Appetite - increased (1,600 drugs)

Browse all the conditions that are associated with Appetite - increased:

Appetite - increased (2,026 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cariprazine hydrochloride (the active ingredients of Vraylar) and Vraylar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.